/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | MDNCMedinotec Inc. |
|---|---|
| Last close | no stored close |
| Change % | no stored close |
| Market cap | no stored close |
| P/E | no stored close |
| Revenue | $10M⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenues As ofFY ending 2026-02-28 Filing10-K · 0001663577-26-000175 · filed 2026-05-28 Open the filing on EDGAR → |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | 6.8%FY to 2026-02-28 |
| Net income | $794502⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2026-02-28 Filing10-K · 0001663577-26-000175 · filed 2026-05-28 Open the filing on EDGAR →Open the XBRL payload →CiteMedinotec Inc. (MDNC), us-gaap:NetIncomeLoss: 794,502 USD, fiscal year ended 2026-02-28. Form 10-K, accession 0001663577-26-000175, filed 2026-05-28. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001931055/us-gaap/NetIncomeLoss.json |
| Net margin | 8.2%FY to 2026-02-28 |
| EPS (diluted) | no EPS filed |
| Piotroski F-ScoreUNVALIDATED | 6FY to 2026-02-28 |
| Altman Z-ScoreUNVALIDATED | inputs not filed |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | rep. 02-08 |